BioCentury
ARTICLE | Clinical News

Narusus regulatory update

April 4, 2017 9:49 PM UTC

Japan approved Narusus hydromorphone tablets from Daiichi to treat cancer pain. The product is a once-daily, extended-release formulation of hydromorphone. Daiichi also said Japan approved Narurapid h...